Market Research Logo

Drug Delivery Markets, Vol III: Pulmonary Delivery Systems

The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality.

The pulmonary drug delivery market reached $25.5 billion in 2006 and is expected to experience high steady growth in the next five years. Contributing to growth are new technologies such as dry powder inhalers and new product offerings that require advanced drug delivery. Pulmonary drug delivery offers the potential for non-invasive administration of a wide variety of macromolecules. Nearly every biotherapeutic product that treats chronic or long-term illness would benefit from noninvasive delivery by providing a competitive advantage with current therapeutics. This advantage could expand the market for each product or enable new indications to be considered.

Kalorama’s Drug Delivery Markets. Edition 2 Volume III: Pulmonary Delivery Systems, the third volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for pulmonary delivery system markets. The report covers both pharmaceuticals sold through pulmonary delivery systems and the technologies themselves

The report provides current market size and revenue for the following main categories:

  • Inhalation drug delivery
  • Intranasal drug delivery

Kalorama believes the future of drug administration by inhalation will expand vastly and be a significant driver in this market. Serious market-watchers who are looking at new products or ways to expand existing products will find this information essential.

As part of its comprehensive cooverage, Kalorama's report includes:

  • A Breakdown of Demographics and Trends that will drive pulmonary delivery.
  • New Developments including Prodrug Technology, Electrohydrodynamic
    Aerosol Delivery, Oxygen Delivery and Crystallization Technology
  • Detailed Discussion of Current Products in pulmonary drug delivery.
  • Current Market Size and Forecasts to 2010.
  • Review of Pipleline products
  • Profiles of Key Companies in the Pulmonary Delivery markets.

As part of Kalorama's trusted information-gathering process, industry executives are interviewed. While government and company data is culled, it is interviews with executives that provide the foundation for market sizes and forecasts.

Kalorama's coverage of the pulmonary drug delivery market includes coverage of the following companies in this field:

  • 3M
  • Alkermes
  • Aradigm
  • Elan
  • Nastech
  • Nektar
  • SkyePharma


  • Executive Summary
    • MARKET DRIVERS
    • MARKET SIZE AND GROWTH
      • The Total Pulmonary Drug Delivery Market
        • Table The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
      • The Total Pulmonary Drug Delivery Only Market
        • Table The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
    • COMPETITOR AND MARKET ANALYSIS
  • Introduction and Overview
    • SCOPE AND METHODOLOGY
    • REASONS FOR PULMONARY DRUG DELIVERY SYSTEMS
    • HISTORY AND MECHANICS OF PULMONARY DRUG DELIVERY
    • PHASES OF DRUG ACTION
      • Table Sequence of Drug Action
    • PHARMACOKINETICS OF INHALATION
    • INHALATION DELIVERY TECHNOLOGIES
      • Metered Dose Inhalers
      • Dry Powder Formulations
      • Nebulizer Delivery Formulations
      • Liquid Formulations
    • NANOSPHERES
    • INTRANASAL DELIVERY TECHNOLOGIES
  • Trends and Demographics
    • ASTHMA
      • Table Worldwide Prevalence of Asthma 2006
      • Table Worldwide Prevalence of Asthma 2006
      • Table World Population by Age Group 2002-2010
    • OPPORTUNITIES FOR DRUG DELIVERY SYSTEM SUCCESS
    • EXUBERA BREAKTHROUGH
    • NANO AND MICROPARTICULATE SYSTEMS
    • TRENDS IN LIQUID AEROSOLS
    • CFC PHASE OUT
    • EXPANSION OF BIOTECHNOLOGY
    • MACROMOLECULE DELIVERY
  • New Developments
    • PRODRUG DRUG DELIVERY
    • ELECTROHYDRODYNAMIC AEROSOL DELIVERY
    • OXYGEN DELIVERY
    • CRYSTALLIZATION TECHNOLOGY
  • Market Size and Growth
    • THE TOTAL PULMONARY DRUG DELIVERY MARKET
      • Table The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
      • Table The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems by Type 2002-2010
      • Table The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies Market Share by Type 2002-2010
    • PULMONARY DELIVERY TECHNOLOGY ONLY MARKET
      • Table The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
      • Table The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
  • Competitive and Market Analysis
    • COMPETITOR ANALYSIS
      • Table Selected Leading and Emerging Suppliers of Pulmonary Drug Delivery Technology
    • MARKET ANALYSIS
  • Company Profiles
    • 3M PHARMACEUTICALS
    • ALKERMES, INC.
    • ARADIGM CORPORATION
    • ELAN CORPORATION, PLC
    • INNOVATA BIOMED PLC
    • MICRODOSE TECHNOLOGY, INC
    • NASTECH PHARMACEUTICAL COMPANY INC.
    • NEKTAR THERAPEUTICS
    • ORIEL THERAPEUTICS
    • PIPEX PHARMACEUTICALS
    • RESIPRICS, INC.
    • SKYEPHARMA PLC
    • VECTURA LTD.
    • VENTAIRA PHARMACEUTICALS, INC.
  • Companies in Brief
    • BESPAK
    • DIRECT HALER A/S
    • INTRANASAL THERAPEUTICS
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report